Contemporary Clinical Dentistry
  Home | About us | Editorial board | Search
Ahead of print | Current Issue | Archives | Advertise
Instructions | Online submission| Contact us | Subscribe |


Login  | Users Online: 64  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 

Year : 2014  |  Volume : 5  |  Issue : 2  |  Page : 268-271

Successful management of phenytoin and phenobarbitone induced gingival enlargement: A multimodal approach

Department of Periodontics, Bapuji Dental College and Hospital, Davangere, Karnataka

Correspondence Address:
M G Triveni
Department of Periodontics, Bapuji Dental College and Hospital, Davangere 577 004, Karnataka

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0976-237X.132365

Rights and Permissions

Medication-related gingival enlargement is a common reactionary phenomenon that occurs with the use of several types of therapeutic agents, including antiepileptic drugs (AEDs). This disorder has been documented since 1939, shortly after the introduction of phenytoin. In the present case, a concise review of literature concerning the etiopathogenesis and management of AEDs (phenobarbitone and phenytoin) induced gingival enlargement has been described. It is vital that not only the periodontist, but also dental surgeons and medical practitioners should become aware of the potential etiologic agents, characteristic features, and the differential diagnosis of drug induced gingival enlargement in order to be able to prevent, diagnose and successfully manage the condition.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded221    
    Comments [Add]    

Recommend this journal